109 related articles for article (PubMed ID: 15370294)
1. Inhibitors of differentiation/DNA binding proteins Id1 and Id3 are regulated by statins in endothelial cells.
Pammer J; Reinisch C; Kaun C; Tschachler E; Wojta J
Endothelium; 2004; 11(3-4):175-80. PubMed ID: 15370294
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
[TBL] [Abstract][Full Text] [Related]
3. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
[TBL] [Abstract][Full Text] [Related]
4. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome.
Berse M; Bounpheng M; Huang X; Christy B; Pollmann C; Dubiel W
J Mol Biol; 2004 Oct; 343(2):361-70. PubMed ID: 15451666
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
7. Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27.
Chen K; Perez-Stable C; D'Ippolito G; Schiller PC; Roos BA; Howard GA
Bone; 2011 Dec; 49(6):1194-204. PubMed ID: 21907315
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of helix-loop-helix proteins ID1, ID2 and ID3.
Nagata Y; Shoji W; Obinata M; Todokoro K
Biochem Biophys Res Commun; 1995 Feb; 207(3):916-26. PubMed ID: 7864897
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.
Dimmeler S; Aicher A; Vasa M; Mildner-Rihm C; Adler K; Tiemann M; Rütten H; Fichtlscherer S; Martin H; Zeiher AM
J Clin Invest; 2001 Aug; 108(3):391-7. PubMed ID: 11489932
[TBL] [Abstract][Full Text] [Related]
10. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of phosphatidylinositol 3-kinase/Akt, mitogen-activated protein kinase, and AMP-activated protein kinase pathways during menadione-induced oxidative stress in the kidney of young and old rats.
Jin Q; Jhun BS; Lee SH; Lee J; Pi Y; Cho YH; Baik HH; Kang I
Biochem Biophys Res Commun; 2004 Mar; 315(3):555-61. PubMed ID: 14975736
[TBL] [Abstract][Full Text] [Related]
12. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
14. TRB3 mediates homocysteine-induced inhibition of endothelial cell proliferation.
Zou T; Liu WJ; Li SD; Zhou W; Yang JF; Zou CG
J Cell Physiol; 2011 Nov; 226(11):2782-9. PubMed ID: 21935927
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cells.
Zingg D; Riesterer O; Fabbro D; Glanzmann C; Bodis S; Pruschy M
Cancer Res; 2004 Aug; 64(15):5398-406. PubMed ID: 15289348
[TBL] [Abstract][Full Text] [Related]
16. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression.
Torella D; Rota M; Nurzynska D; Musso E; Monsen A; Shiraishi I; Zias E; Walsh K; Rosenzweig A; Sussman MA; Urbanek K; Nadal-Ginard B; Kajstura J; Anversa P; Leri A
Circ Res; 2004 Mar; 94(4):514-24. PubMed ID: 14726476
[TBL] [Abstract][Full Text] [Related]
17. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin prevents oxidized low-density lipoprotein-induced injury of renal tubular epithelial cells by inhibiting the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Chu G; Jia R; Yang D
J Nephrol; 2006; 19(3):286-95. PubMed ID: 16874687
[TBL] [Abstract][Full Text] [Related]
19. Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line.
Bertrand-Thiebault C; Masson C; Siest G; Batt AM; Visvikis-Siest S
J Cardiovasc Pharmacol; 2007 May; 49(5):306-15. PubMed ID: 17513950
[TBL] [Abstract][Full Text] [Related]
20. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation.
Yamaoka-Tojo M; Ushio-Fukai M; Hilenski L; Dikalov SI; Chen YE; Tojo T; Fukai T; Fujimoto M; Patrushev NA; Wang N; Kontos CD; Bloom GS; Alexander RW
Circ Res; 2004 Aug; 95(3):276-83. PubMed ID: 15217908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]